Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04833829 · ClinicalTrials.gov registry record · NA

Cross-disciplinary HIV Integrated Mental Health Support Intervention

A NA study of HIV Infections and Human Immunodeficiency Virus, sponsored by Emory University.

Active
Registry status
NA
Development phase
850
Enrollment target
2
Study locations

NCT04833829: Active NA study of HIV Infections and Human Immunodeficiency Virus, sponsored by Emory University.

NCT04833829 is a NA study of HIV Infections and Human Immunodeficiency Virus that is active but no longer recruiting, run by Emory University. The registered enrollment target is 850 participants, above the 444-participant average among 542 other HIV Infections trials with a reported enrollment target (91% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04833829, a NA study of HIV Infections and Human Immunodeficiency Virus, is active but no longer recruiting, sponsored by Emory University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
850 participants
Enrollment target
2
Study locations

Study Summary

The proposed project seeks to develop and test an intervention to improve engagement in HIV and mental health care for young Black gay, bisexual and other men who have sex with men (YB-GBMSM) in Ryan White clinics.

Primary Outcome

The number of mental health visits by clinic patients during each study time period.

Interventions

  • BEHAVIORAL Standard of Care
  • BEHAVIORAL CHIMES Intervention

Study Locations (2)

Georgia

  • Grady Infectious Diseases Clinic (Ponce Clinic) - Atlanta
  • Emory Midtown Hospital Infectious Disease Outpatient Clinic - Atlanta

Trial Details

FieldValue
Enrollment Target 850 participants
Start Date 2020-11-01
Est. Completion 2026-11
Phase NA
Emory University

1,208 total trials

What the registry record for NCT04833829 still lists

NCT04833829 is an interventional study that assigns participants to a tested intervention. The registered 850 participants enrollment target is mid-sized for trials with a published cap, above the 444-participant average among 542 other HIV Infections trials with a reported enrollment target (91% higher).

The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.

NCT04833829 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT04833829 about?

NCT04833829 is a clinical study titled "Cross-disciplinary HIV Integrated Mental Health Support Intervention". The proposed project seeks to develop and test an intervention to improve engagement in HIV and mental health care for young Black gay, bisexual and other men who have sex with men (YB-GBMSM) in Ryan White clinics.

What is the current status of trial NCT04833829?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 850 participants. The study started on 2020-11-01. Estimated completion is 2026-11.

What conditions does trial NCT04833829 study?

This clinical trial studies the following conditions: HIV Infections, Human Immunodeficiency Virus.

What interventions are being tested in trial NCT04833829?

The interventions under investigation include: Standard of Care (BEHAVIORAL), CHIMES Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT04833829?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04833829 being conducted?

This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04833829's enrollment target sits among peer trials

850 36th of 542 higher than 507 of 542 other HIV Infections trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03507257 · 850 participants

    Longitudinal Early-onset Alzheimer's Disease Study Protocol

  • NCT05846841 · 850 participants · NA

    Personalized Tobacco Treatment in Primary Care (MOTIVATE)

  • NCT05987059 · 850 participants · Phase 2

    Involving Communities in Addressing the Maternal Health Crisis: Making an IMPACT

  • NCT06289673 · 850 participants · Phase 4

    Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04833829, the US trial registry maintained by the National Library of Medicine. NCT04833829 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.